Form 8-K - Current report:
SEC Accession No. 0001193125-24-280821
Filing Date
2024-12-18
Accepted
2024-12-18 07:00:30
Documents
13
Period of Report
2024-12-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d129233d8k.htm   iXBRL 8-K 24626
  Complete submission text file 0001193125-24-280821.txt   142780

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20241217.xsd EX-101.SCH 2867
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20241217_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20241217_pre.xml EX-101.PRE 10824
16 EXTRACTED XBRL INSTANCE DOCUMENT d129233d8k_htm.xml XML 3521
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 241557580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)